-
Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease.
Transplantation. 1996 Nov 15;62(9):1278-85
PMID: 8932272
-
The Th1/Th2 paradigm and the allograft response.
Curr Opin Immunol. 1996 Oct;8(5):688-93
PMID: 8902395
-
Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease.
J Immunol. 1997 Aug 1;159(3):1208-15
PMID: 9233615
-
The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation.
Immunol Rev. 1997 Jun;157:167-76
PMID: 9255629
-
Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.
Blood. 1997 Oct 15;90(8):3204-13
PMID: 9376604
-
Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection.
J Clin Invest. 1997 Nov 15;100(10):2449-56
PMID: 9366559
-
An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.
J Exp Med. 1998 Feb 16;187(4):537-46
PMID: 9463404
-
Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
J Immunol. 1998 Jul 15;161(2):631-40
PMID: 9670937
-
Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma.
J Immunol. 1988 Mar 1;140(5):1506-10
PMID: 3126227
-
Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells.
Proc Natl Acad Sci U S A. 1990 Aug;87(15):5633-7
PMID: 2377601
-
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.
Science. 1993 Mar 19;259(5102):1739-42
PMID: 8456300
-
Disruption of the murine IL-4 gene blocks Th2 cytokine responses.
Nature. 1993 Mar 18;362(6417):245-8
PMID: 8384701
-
Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice.
J Immunol. 1993 Dec 1;151(11):6451-9
PMID: 8245478
-
Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment.
J Immunol. 1994 Feb 1;152(3):1004-13
PMID: 7905495
-
Effects of exogenous interleukin-10 in a murine model of graft-versus-host disease to minor histocompatibility antigens.
Transplantation. 1994 Dec 15;58(11):1251-7
PMID: 7992370
-
Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts.
Blood. 1995 Feb 1;85(3):842-51
PMID: 7833486
-
Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
J Immunol. 1995 Mar 15;154(6):2687-96
PMID: 7876541
-
Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.
Blood. 1995 May 1;85(9):2607-18
PMID: 7537122
-
IL-2-induced GVHD protection is not inhibited by cyclosporine and is maximal when IL-2 is given over a 25 h period beginning on the day following bone marrow transplantation.
Bone Marrow Transplant. 1995 Mar;15(3):395-9
PMID: 7599564
-
Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
J Immunol. 1995 Jul 15;155(2):585-93
PMID: 7608537
-
The regulation of immunity to Leishmania major.
Annu Rev Immunol. 1995;13:151-77
PMID: 7612219
-
Interleukin-12 inhibits murine graft-versus-host disease.
Blood. 1995 Sep 15;86(6):2429-38
PMID: 7662991
-
Presence of host-specific interleukin 2-secreting T helper cell precursors correlates closely with active primary and secondary chronic graft-versus-host disease.
Bone Marrow Transplant. 1995 May;15(5):727-32
PMID: 7670402
-
Bone marrow transplantation.
Transplant Proc. 1995 Oct;27(5):2649-52
PMID: 7482865
-
Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE).
J Immunol. 1996 Jan 1;156(1):5-7
PMID: 8598493
-
Dysregulation of cytokines during graft-versus-host disease.
J Hematother. 1996 Feb;5(1):3-14
PMID: 8646479
-
Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease.
Blood. 1996 Aug 1;88(3):1113-21
PMID: 8704222
-
The role of tumor necrosis factor and interferon gamma in graft-versus-host disease and related immunodeficiency.
Transplantation. 1994 Jan;57(2):273-9
PMID: 8310520
-
Graft-versus-host disease and the Th1/Th2 paradigm.
Immunol Res. 1996;15(1):50-73
PMID: 8739565
-
Accelerated clearance of Onchocerca microfilariae and resistance to reinfection in interleukin-4 gene knockout mice.
Parasite Immunol. 1995 Dec;17(12):653-7
PMID: 8834765
-
The immunopathophysiology of acute graft-versus-host-disease.
Stem Cells. 1996 Sep;14(5):473-89
PMID: 8888489
-
Interferon-gamma-mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice.
Bone Marrow Transplant. 1997 Mar;19(6):601-6
PMID: 9085739